JPWO2023127918A5 - - Google Patents
Info
- Publication number
- JPWO2023127918A5 JPWO2023127918A5 JP2023571077A JP2023571077A JPWO2023127918A5 JP WO2023127918 A5 JPWO2023127918 A5 JP WO2023127918A5 JP 2023571077 A JP2023571077 A JP 2023571077A JP 2023571077 A JP2023571077 A JP 2023571077A JP WO2023127918 A5 JPWO2023127918 A5 JP WO2023127918A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- solution containing
- nucleic acid
- defined above
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021212132 | 2021-12-27 | ||
| PCT/JP2022/048385 WO2023127918A1 (ja) | 2021-12-27 | 2022-12-27 | オリゴ核酸化合物の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023127918A1 JPWO2023127918A1 (cg-RX-API-DMAC7.html) | 2023-07-06 |
| JPWO2023127918A5 true JPWO2023127918A5 (cg-RX-API-DMAC7.html) | 2025-07-28 |
Family
ID=86999200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571077A Pending JPWO2023127918A1 (cg-RX-API-DMAC7.html) | 2021-12-27 | 2022-12-27 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250066396A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4458833A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2023127918A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240129006A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118488959A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022424485A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3244382A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023127918A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE312834T1 (de) | 1989-12-20 | 2005-12-15 | Avi Biopharma Inc | Ungeladene, auf morpholin basierende polymere mit chiralen, phosphor enthaltenden brücken zwischen den untereinheiten |
| AU5752601A (en) | 2000-05-04 | 2001-11-12 | Avi Biopharma Inc | Splice-region antisense composition and method |
| ES2627917T3 (es) | 2004-06-28 | 2017-08-01 | The University Of Western Australia | Oligonucleótidos no codificantes para la inducción de la omisión exónica y métodos de uso de los mismos |
| US7790694B2 (en) | 2005-07-13 | 2010-09-07 | Avi Biopharma Inc. | Antisense antibacterial method and compound |
| MX2010004955A (es) | 2007-11-15 | 2010-06-30 | Avi Biopharma Inc | Metodo de sintesis de oligomeros de morfolina. |
| EP3133160B1 (en) | 2008-10-24 | 2018-12-12 | Sarepta Therapeutics, Inc. | Exon skipping compositions for dmd |
| SI2607484T1 (sl) | 2008-10-27 | 2016-11-30 | Biomarin Technologies B.V. | Metode in sredstva za učinkovito preskakovanje eksona 45 v pre-mRNA Duchennove mišične distrofije |
| HUE040445T2 (hu) | 2009-11-12 | 2019-03-28 | Univ Western Australia | Antiszensz molekulák és eljárások betegségek kezelésére |
| TWI541024B (zh) | 2010-09-01 | 2016-07-11 | 日本新藥股份有限公司 | 反義核酸 |
| CN103154009B (zh) * | 2010-09-30 | 2015-06-10 | 日本新药株式会社 | 吗啉基核酸衍生物 |
| CN108588073A (zh) | 2011-12-28 | 2018-09-28 | 日本新药株式会社 | 反义核酸 |
| IN2014DN06768A (cg-RX-API-DMAC7.html) | 2012-02-17 | 2015-05-22 | Ajinomoto Kk | |
| US10214555B2 (en) | 2012-11-14 | 2019-02-26 | Takeda Pharmaceutical Company Limitjed | Method for liquid-phase synthesis of nucleic acid |
| EP3760720A1 (en) | 2013-03-14 | 2021-01-06 | Sarepta Therapeutics, Inc. | Exon skipping compositions for treating muscular dystrophy |
| HK1220154A1 (zh) | 2013-03-15 | 2017-04-28 | Sarepta Therapeutics, Inc. | 改进的用於治疗肌营养不良的组合物 |
| JP6477464B2 (ja) * | 2013-05-24 | 2019-03-06 | 味の素株式会社 | モルフォリノオリゴヌクレオチドの製造方法 |
| BR112016020618B1 (pt) | 2014-03-12 | 2023-04-04 | Nippon Shinyaku Co., Ltd. | Oligômero antissentido, composição farmacêutica, e, uso de um oligômero antissentido |
| PT3159409T (pt) | 2014-06-17 | 2020-01-21 | Nippon Shinyaku Co Ltd | Ácido nucleico anti-sentido para utilização no tratamento da distrofia muscular de duchenne |
| HUE050061T2 (hu) | 2015-09-15 | 2020-12-28 | Nippon Shinyaku Co Ltd | Antiszensz nukleinsav |
| US11560401B2 (en) * | 2018-05-10 | 2023-01-24 | Nippon Shinyaku Co., Ltd. | Method for preparing oligonucleic acid compound |
| JP6770553B2 (ja) * | 2018-07-20 | 2020-10-14 | 藤本化学製品株式会社 | アルコキシフェニル誘導体、ヌクレオシド保護体およびヌクレオチド保護体、オリゴヌクレオチド製造方法、ならびに、置換基除去方法 |
| EP4059944A4 (en) * | 2019-11-13 | 2024-04-10 | Nippon Shinyaku Co., Ltd. | METHOD FOR PREPARING AN OLIGONUCLICE ACID COMPOUND |
| EP4059943A4 (en) * | 2019-11-13 | 2024-01-31 | Nippon Shinyaku Co., Ltd. | METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND |
| IL294271A (en) | 2019-12-26 | 2022-08-01 | Nippon Shinyaku Co Ltd | Antisense nucleic acid that induces skipping of exon 50 |
| PE20230237A1 (es) | 2020-02-28 | 2023-02-07 | Nippon Shinyaku Co Ltd | Acidos nucleicos antisentido que inducen la omision del exon 51 |
| CN117279926A (zh) * | 2021-04-28 | 2023-12-22 | 日本新药株式会社 | 低聚核酸化合物的制造方法 |
-
2022
- 2022-12-27 KR KR1020247025422A patent/KR20240129006A/ko active Pending
- 2022-12-27 CN CN202280086091.8A patent/CN118488959A/zh active Pending
- 2022-12-27 JP JP2023571077A patent/JPWO2023127918A1/ja active Pending
- 2022-12-27 EP EP22916140.1A patent/EP4458833A4/en active Pending
- 2022-12-27 AU AU2022424485A patent/AU2022424485A1/en active Pending
- 2022-12-27 US US18/723,577 patent/US20250066396A1/en active Pending
- 2022-12-27 WO PCT/JP2022/048385 patent/WO2023127918A1/ja not_active Ceased
- 2022-12-27 CA CA3244382A patent/CA3244382A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4945129B2 (ja) | フルオラス担体およびそれを用いたオリゴヌクレオチド誘導体の製造方法 | |
| ES2745504T3 (es) | Acidos nucleicos peptídicos gamma que contienen miniPEG preorganizados conformacionalmente | |
| JP5548852B2 (ja) | 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法 | |
| KR102504759B1 (ko) | 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법 | |
| CN109563114B (zh) | 用于制备寡聚物的方法 | |
| KR102523522B1 (ko) | 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법 | |
| JP3675847B2 (ja) | ヌクレオチド又はオリゴヌクレオチドホスホロアミダイトの合成方法 | |
| TWI848981B (zh) | 新穎亞磷醯胺、及髮夾型單股rna分子之製造方法 | |
| KR102523527B1 (ko) | 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법 | |
| CN115335387A (zh) | 核酸寡聚物的制造方法 | |
| JP6537338B2 (ja) | 核酸固相合成用リンカー及び担体 | |
| JP2022183382A (ja) | 改善されたイメテルスタットの調製方法 | |
| JP2021522806A (ja) | 光活性化された作用物質を使用してポリヌクレオチドアレイを合成する方法 | |
| JP7475056B2 (ja) | 光応答性ヌクレオチドアナログの製造方法 | |
| JP7298866B2 (ja) | 核酸合成用固相担体及びそれを用いた核酸の製造方法 | |
| JP5808025B2 (ja) | アミノ化オリゴヌクレオチド用固相担体 | |
| JP6429264B2 (ja) | ボラノホスフェート化合物、及び核酸オリゴマー | |
| WO2007013190A1 (ja) | オリゴヌクレオチドプローブ | |
| CN118488959A (zh) | 低聚核酸化合物的制造方法 | |
| RU2787350C1 (ru) | Способ получения морфолиновых олигомеров | |
| HK40113683A (en) | Method for producing oligonucleic acid compound | |
| HK40108064A (en) | Method for producing oligonucleic acid compound |